Active	Status	Sponsor type	Region	Phase	Filter
3 Active 8 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schefold, Joerg C
RECREATE, NCT03892174: Cytokine REmoval in CRitically Ill PAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE)	Recruiting	N/A	54	Europe	Treatment protocol with adsorption	Insel Gruppe AG, University Hospital Bern	Endocarditis, Sepsis, Septic Shock	11/24	12/24
(RESTORE), NCT06258291: First in Human Trial to Assess the Safety of HemoSystem REBOOT in Patients With Sepsis-induced Immunosuppression	Not yet recruiting	N/A	16	Europe	Hemosystem REBOOT, extracorporeal blood purification	hemotune AG	Septic Shock	07/25	03/26
PhINEST, NCT03840395: The Study - Pharyngeal ICU Novel Electrical Stimulation Therapy	Recruiting	N/A	360	Europe	Pharyngeal Electrical Stimulation (PES), Phagenyx	Phagenesis Ltd., NAMSA, Cytel Inc.	Dysphagia	09/25	12/25